Paradox Immunotherapeutics

We are a pharmaceutical company dedicated to the creation of antibody therapies for the treatment of rare protein misfolding diseases, including those characterized by amyloidosis.  Paradox’s scientific team has proven expertise and know-how to selectively target misfolded proteins with monoclonal antibodies with a proven track record of success.

  • Tags: FemTech, Pharmaceutical, Therapeutics